WHALEROCK POINT PARTNERS, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
WHALEROCK POINT PARTNERS, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$367,000
+282.3%
84,900
+162.0%
0.15%
+265.9%
Q4 2014$96,000
-4.0%
32,400
+6.6%
0.04%
-8.9%
Q3 2014$100,00030,4000.04%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders